34195421|t|Mito-Tempo suppresses autophagic flux via the PI3K/Akt/mTOR signaling pathway in neuroblastoma SH-SY5Y cells.
34195421|a|The generation of excessive mitochondrial reactive oxygen species (mtROS) is associated with glutamate-stimulated neurotoxicity and pathogenesis of Alzheimer's disease (AD). Impaired mitochondrial function is accompanied with oxidative stress that is a significant contributor to initiate autophagy, but the underlying mechanisms are not fully understood. The present study aimed to investigate the neuroprotective effects of Mito-Tempo on glutamate-induced neuroblastoma SH-SY5Y cell toxicity. SH-SY5Y cells were treated with 100 muM glutamate in the presence or absence of 50 and 100 muM Mito-Tempo for 24 h. Changes in cell viability were measured by MTT assay. Cytotoxicity and intracellular ROS accumulation were also evaluated using lactate dehydrogenase (LDH) activity assay and 2,7-dichlorofluorescein diacetate (DCFDA) Reactive Oxygen Species Assay kit, respectively. Mitochondrial membrane potential was analyzed by tetraethylbenzimidazoly-lcarbocyanine iodide (JC-1) staining. Expression of PI3K/AKT/mTOR pathway and autophagy markers, including LC3 (LC3-I/-II) and p62 (SQSTM1) were performed using Western blot analysis. Our results demonstrated that glutamate-exposed cells significantly increased cellular oxidative stress by enhancing ROS production. Glutamate treatment also increased LDH release follows the loss of mitochondrial membrane potential, caused cell viability loss. Treatment with Mito-Tempo not only attenuated the generation of ROS and improved mitochondrial membrane potential but also reduced the neurotoxicity of glutamate in a concentration-dependent manner, which leads to increased cell viability and decreased LDH release. Mito-Tempo has a greater protective effect by enhancing superoxide dismutase (SOD) activity and PI3K/AKT/mTOR phosphorylation. Moreover, Mito-Tempo treatment altered the autophagy process resulting in the decline in the ratio of the autophagy markers LC3-I/-II and p62 (SQSTM1). We propose that Mito-Tempo can improve neuronal properties against glutamate cytotoxicity through its direct free radical scavenging activity and inhibit excessive autophagy signaling pathway, therefore, allow for further studies to investigate the therapeutic potentials of Mito-Tempo in animal disease models and human.
34195421	0	10	Mito-Tempo	Chemical	MESH:C555916
34195421	51	54	Akt	Gene	207
34195421	55	59	mTOR	Gene	2475
34195421	81	94	neuroblastoma	Disease	MESH:D009447
34195421	95	102	SH-SY5Y	CellLine	CVCL:0019
34195421	152	175	reactive oxygen species	Chemical	MESH:D017382
34195421	177	182	mtROS	Chemical	-
34195421	203	212	glutamate	Chemical	MESH:D018698
34195421	224	237	neurotoxicity	Disease	MESH:D020258
34195421	258	277	Alzheimer's disease	Disease	MESH:D000544
34195421	279	281	AD	Disease	MESH:D000544
34195421	293	315	mitochondrial function	Disease	MESH:D028361
34195421	536	546	Mito-Tempo	Chemical	MESH:C555916
34195421	550	559	glutamate	Chemical	MESH:D018698
34195421	568	581	neuroblastoma	Disease	MESH:D009447
34195421	582	589	SH-SY5Y	CellLine	CVCL:0019
34195421	595	603	toxicity	Disease	MESH:D064420
34195421	605	612	SH-SY5Y	CellLine	CVCL:0019
34195421	645	654	glutamate	Chemical	MESH:D018698
34195421	700	710	Mito-Tempo	Chemical	MESH:C555916
34195421	764	767	MTT	Chemical	MESH:C070243
34195421	775	787	Cytotoxicity	Disease	MESH:D064420
34195421	806	809	ROS	Chemical	MESH:D017382
34195421	896	929	2,7-dichlorofluorescein diacetate	Chemical	MESH:C029569
34195421	931	936	DCFDA	Chemical	MESH:C029569
34195421	938	961	Reactive Oxygen Species	Chemical	MESH:D017382
34195421	1036	1080	tetraethylbenzimidazoly-lcarbocyanine iodide	Chemical	-
34195421	1082	1086	JC-1	Chemical	MESH:C068624
34195421	1117	1120	AKT	Gene	207
34195421	1121	1125	mTOR	Gene	2475
34195421	1167	1170	LC3	Gene	84557
34195421	1172	1175	LC3	Gene	84557
34195421	1187	1190	p62	Gene	8878
34195421	1192	1198	SQSTM1	Gene	8878
34195421	1274	1283	glutamate	Chemical	MESH:D018698
34195421	1361	1364	ROS	Chemical	MESH:D017382
34195421	1377	1386	Glutamate	Chemical	MESH:D018698
34195421	1521	1531	Mito-Tempo	Chemical	MESH:C555916
34195421	1570	1573	ROS	Chemical	MESH:D017382
34195421	1641	1654	neurotoxicity	Disease	MESH:D020258
34195421	1658	1667	glutamate	Chemical	MESH:D018698
34195421	1772	1782	Mito-Tempo	Chemical	MESH:C555916
34195421	1828	1848	superoxide dismutase	Gene	6647
34195421	1850	1853	SOD	Gene	6647
34195421	1873	1876	AKT	Gene	207
34195421	1877	1881	mTOR	Gene	2475
34195421	1909	1919	Mito-Tempo	Chemical	MESH:C555916
34195421	2023	2026	LC3	Gene	84557
34195421	2037	2040	p62	Gene	8878
34195421	2042	2048	SQSTM1	Gene	8878
34195421	2067	2077	Mito-Tempo	Chemical	MESH:C555916
34195421	2118	2127	glutamate	Chemical	MESH:D018698
34195421	2128	2140	cytotoxicity	Disease	MESH:D064420
34195421	2326	2336	Mito-Tempo	Chemical	MESH:C555916
34195421	2366	2371	human	Species	9606
34195421	Negative_Correlation	MESH:D018698	MESH:D009447
34195421	Positive_Correlation	MESH:C555916	2475
34195421	Positive_Correlation	MESH:C555916	6647
34195421	Negative_Correlation	MESH:C555916	84557
34195421	Negative_Correlation	MESH:C555916	MESH:D018698
34195421	Association	MESH:D009447	2475
34195421	Negative_Correlation	MESH:C555916	8878
34195421	Negative_Correlation	MESH:C555916	MESH:D009447
34195421	Positive_Correlation	MESH:D018698	MESH:D000544
34195421	Negative_Correlation	MESH:C555916	MESH:D020258
34195421	Association	MESH:D017382	MESH:D020258
34195421	Positive_Correlation	MESH:D018698	MESH:D020258
34195421	Association	MESH:D017382	MESH:D000544
34195421	Negative_Correlation	MESH:C555916	MESH:D017382
34195421	Association	MESH:D009447	207
34195421	Positive_Correlation	MESH:D017382	MESH:D018698
34195421	Positive_Correlation	MESH:C555916	207
34195421	Association	207	2475

